CombiMatrix appoints three new execs

July 12, 2005 — Acacia Research Corp. (Nasdaq: ACTG) announced the expansion of the management team at CombiMatrix Molecular Diagnostics, a wholly-owned subsidiary of Acacia operating group CombiMatrix (Nasdaq: CBMX) and a cancer-based molecular diagnostics company based in Irvine, California.

The company named Matthew Moore as director of research and development, Robert Embree as director of laboratory operations and John Besser as chief financial officer. Moore and Embree were previously with US LABS. Besser was at Quest Diagnostics Nichols Institute.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.